Grufity logoGrufity logo

Perrigo Company PLC Stock Research

PRGO

33.98USD-0.59(-1.71%)Market Closed

Market Summary

USD33.98-0.59
Market Closed
-1.71%

PRGO Alerts

PRGO Stock Price

PRGO RSI Chart

PRGO Valuation

Market Cap

4.8B

Price/Earnings (Trailing)

-34.17

Price/Sales (Trailing)

1.08

Price/Free Cashflow

22.78

PRGO Price/Sales (Trailing)

PRGO Profitability

Return on Equity

-2.9%

Return on Assets

-1.28%

Free Cashflow Yield

4.39%

PRGO Fundamentals

PRGO Revenue

Revenue (TTM)

4.5B

Revenue Y/Y

4.56%

Revenue Q/Q

5.01%

PRGO Earnings

Earnings (TTM)

-140.6M

Earnings Y/Y

-346.88%

Earnings Q/Q

52.02%

Price Action

52 Week Range

30.7843.90
(Low)(High)

Last 7 days

-3.2%

Last 30 days

-0.2%

Last 90 days

12.5%

Trailing 12 Months

-5.4%

PRGO Financial Health

Current Ratio

2.44

PRGO Investor Care

Dividend Yield

2.91%

Dividend/Share (TTM)

1.04

Shares Dilution (1Y)

0.60%

Diluted EPS (TTM)

-1.04

Peers (Alternatives to Perrigo Company)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
404.8B
94.9B
-5.16% -10.64%
22.56
4.26
1.25% -14.07%
296.8B
28.5B
-5.67% 20.74%
47.53
10.4
0.79% 11.88%
272.8B
59.3B
-1.75% 40.02%
17.88
4.63
21.72% 11.27%
226.4B
100.3B
-8.43% -20.95%
7.22
2.26
23.43% 42.74%
142.7B
46.2B
-7.78% -1.12%
22.55
3.09
-0.49% -9.54%
MID-CAP
4.8B
4.5B
-0.20% -5.41%
-34.17
1.08
7.56% -104.06%
3.3B
2.2M
105.10% 171.03%
-10.52
1.5K
-80.71% -4.88%
SMALL-CAP
1.9B
667.2M
-9.96% 17.66%
31.57
2.87
15.09% 13.64%
1.6B
602.5M
-17.77% -52.80%
-2.74
2.63
18.18% -18.59%
991.7M
478.9M
-11.35% -65.42%
-0.32
2.07
-31.50% -634.70%
792.9M
285.2M
-7.22% -37.95%
3.6
2.78
-27.21% -40.28%
768.8M
114.5M
-15.28% -37.42%
-4.56
6.72
27.90% 57.40%
541.5M
29.8M
-40.95% -47.43%
-6.23
18.2
340.05% 4.35%
400.7M
51.5M
-2.49% -0.39%
-5.64
7.78
18.32% -984.05%
94.1M
2.3B
-43.99% -88.43%
-0.03
0.04
-22.53% -376.66%

Financials for Perrigo Company

Income Statement (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Revenue1.1%4,4524,4014,3444,2034,139
Gross Profit1.4%1,4551,4351,4091,3861,416
Operating Expenses2.7%1,3771,3419091,0051,006
  S&GA Expenses4.0%585562548537536
  R&D Expenses1.8%123121119120122
Interest Expenses-7.1%-156-145-135-128-125
Net Income-31.0%-140-107-116-109-68.90
Net Income Margin-29.6%-0.03*-0.02*-0.03*-0.03*-
Free Cahsflow320.4%211-95.70168108-
Balance Sheet
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Assets3.2%11,01710,67810,92010,39010,426
  Current Assets5.3%2,7202,5832,6523,9363,860
    Cash Equivalents28.2%6014694851,9661,865
  Inventory6.0%1,1501,0851,0801,0221,020
  Net PPE10.3%926840840846864
  Goodwill-2.4%3,4293,5152,9712,999-
Liabilities1.7%6,1756,0756,0705,2855,274
  Current Liabilities9.7%1,1141,0151,0159811,588
    LT Debt, Current8.1%36.0034.0031.005.00604
    LT Debt, Non Current-0.2%4,0704,0784,0863,5112,917
Shareholder's Equity5.2%4,8424,6034,8505,1055,152
  Retained Earnings-1.2%-2,067-2,043-1,994-1,929-1,927
Shares Outstanding0%135135134--
Cashflow (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Cashflow From Operations1820.6%30716.00301235156
  Share Based Compensation-3.0%55.0057.0058.0061.0060.00
Cashflow From Investing0.8%-1,958-1,974-5001,4531,276
Cashflow From Financing3.8%422406413-187-178
  Dividend Payments2.6%142139134131130
  Buy BacksNaN%0.000.00---

Risks for PRGO

What is the probability of a big loss on PRGO?

87.3%


Probability that Perrigo Company stock will be more than 20% underwater in next one year

37.7%


Probability that Perrigo Company stock will be more than 30% underwater in next one year.

18.9%


Probability that Perrigo Company stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does PRGO drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Perrigo Company was unfortunately bought at previous high price.

Drawdowns

Returns for PRGO

Cumulative Returns on PRGO

-10.2%


10-Year Cumulative Returns

-16.0%


7-Year Cumulative Returns

-14.5%


5-Year Cumulative Returns

-6.8%


3-Year Cumulative Returns

What are the long-term rolling returns for PRGO?

FIve years rolling returns for Perrigo Company.

Annualized Returns

Which funds bought or sold PRGO recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-03-10
VICTORY CAPITAL MANAGEMENT INC
added
2.04
-901,717
35,822,300
0.04%
2023-03-06
Rockefeller Capital Management L.P.
added
108
46,000
91,000
-%
2023-02-28
Voya Investment Management LLC
added
6.81
20,553
987,553
-%
2023-02-24
SRS Capital Advisors, Inc.
added
3.9
-808
58,192
0.01%
2023-02-22
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
added
9.12
31,000
735,000
0.01%
2023-02-21
Insight Advisors, LLC/ PA
new
-
301,350
301,350
0.10%
2023-02-21
MACQUARIE GROUP LTD
reduced
-1.2
-472,000
7,159,000
0.01%
2023-02-21
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
new
-
3,579
3,579
-%
2023-02-17
Coppell Advisory Solutions Corp.
new
-
205
205
-%
2023-02-17
TRUIST FINANCIAL CORP
reduced
-19.37
-2,125,390
7,150,610
0.01%

1–10 of 46

Latest Funds Activity

Are funds buying PRGO calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own PRGO
No. of Funds

Perrigo Company News

Defense World

Toroso Investments LLC Trims Stock Holdings in Perrigo Company ....

Defense World,
26 hours ago

Marketscreener.com

Investing.com UK

London South East

Stock Traders Daily

InvestorsObserver

Perrigo Investor Relations

Perrigo Increases its Quarterly Dividend - Feb 21, 2023.

Perrigo Investor Relations,
30 days ago

Schedule 13G FIlings of Perrigo Company

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 15, 2023
barrow hanley mewhinney & strauss llc
7.30%
9,825,539
SC 13G
Feb 14, 2023
price t rowe associates inc /md/
0.1%
78,305
SC 13G/A
Feb 14, 2023
price t rowe associates inc /md/
0.1%
78,305
SC 13G/A
Feb 09, 2023
vanguard group inc
10.84%
14,590,276
SC 13G/A
Jan 24, 2023
blackrock inc.
9.8%
13,221,594
SC 13G/A
Feb 14, 2022
price t rowe associates inc /md/
8.0%
10,721,574
SC 13G/A
Feb 03, 2022
blackrock inc.
8.6%
11,557,239
SC 13G/A
Jan 10, 2022
barrow hanley mewhinney & strauss llc
10.10%
13,505,133
SC 13G
Nov 10, 2021
price t rowe associates inc /md/
8.4%
11,328,393
SC 13G/A
Sep 10, 2021
price t rowe associates inc /md/
18.0%
24,135,892
SC 13G/A

PRGO Fair Value

Perrigo Company fair value in different scenarios

The table shows the Fair Value estimates for Perrigo Company for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
Fair ValueVery PessimisticPessimisticBase CaseOptimisticVery Optimistic
Very Low Inflation

-

-

-

-

-

-

-

-

-

-
Current Inflation

17.39

-48.82%

19.63

-42.23%

23.67

-30.34%

26.94

-20.72%

29.79

-12.33%
Very High Inflation

-

-

-

-

-

-

-

-

-

-

Historical Perrigo Company Fair Value Estimates


Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price

Recent SEC filings of Perrigo Company

View All Filings
Date Filed Form Type Document
Mar 14, 2023
4
Insider Trading
Mar 14, 2023
4
Insider Trading
Mar 10, 2023
PRE 14A
PRE 14A
Mar 09, 2023
4
Insider Trading
Mar 09, 2023
4
Insider Trading
Mar 08, 2023
4
Insider Trading
Mar 08, 2023
4
Insider Trading
Mar 08, 2023
4
Insider Trading
Mar 08, 2023
4
Insider Trading
Mar 08, 2023
4
Insider Trading

Latest Insider Trading transactions for PRGO

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-03-13
Farrington Thomas
sold
-132,435
35.572
-3,723
evp and cio
2023-03-10
Dillard James E III
sold
-321,309
35.701
-9,000
evp & president csca
2023-03-08
Janish Ronald Craig
sold
-166,133
36.9185
-4,500
evp, gbl ops & sc & cto
2023-03-07
Quinn Grainne
acquired
84,847
37.71
2,250
evp, chief medical officer
2023-03-07
Willis Robert
sold (taxes)
-42,423
37.71
-1,125
evp & chro
2023-03-07
Quinn Grainne
sold (taxes)
-44,120
37.71
-1,170
evp, chief medical officer
2023-03-07
Janish Ronald Craig
acquired
110,943
37.71
2,942
evp, gbl ops & sc & cto
2023-03-07
Ives Alison
acquired
65,841
37.71
1,746
evp & chief scientific officer
2023-03-07
Farrington Thomas
sold (taxes)
-43,705
37.71
-1,159
evp and cio
2023-03-07
KESSLER MURRAY S
sold (taxes)
-446,864
37.71
-11,850
ceo

1–10 of 50

Murray S. Kessler
9900
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

PRGO Income Statement

2022-12-31
Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]   
Net sales$ 4,451.6$ 4,138.7$ 4,088.2
Cost of sales2,996.22,722.52,593.3
Gross profit1,455.41,416.21,494.9
Operating expenses   
Distribution113.093.085.1
Research and development123.1122.0121.7
Selling584.8536.4545.5
Administration512.3482.0478.5
Impairment charges0.0173.10.0
Restructuring42.516.93.2
Other operating expense (income), net0.8(417.6)(4.3)
Total operating expenses1,376.51,005.81,229.7
Operating income78.9410.4265.2
Change in financial assets0.00.095.3
Interest expense, net156.0125.0127.7
Other (income) expense, net53.126.716.3
Loss on extinguishment of debt8.90.020.0
Income (loss) from continuing operations before income taxes(139.1)258.75.9
Income tax expense (benefit)(8.2)389.6(38.3)
Income (loss) from continuing operations(130.9)(130.9)44.2
Income (loss) from discontinued operations, net of tax(9.7)62.0(206.8)
Net income (loss)$ (140.6)$ (68.9)$ (162.6)
Basic   
Continuing operations (in dollars per share)$ (0.97)$ (0.98)$ 0.32
Discontinued operations (in dollars per share)(0.07)0.46(1.52)
Basic (in dollars per share)(1.04)(0.52)(1.20)
Diluted   
Continuing operations (in dollars per share)(0.97)(0.98)0.32
Discontinued operations (in dollars per share)(0.07)0.46(1.51)
Diluted (in dollars per share)$ (1.04)$ (0.52)$ (1.19)
Weighted-average shares outstanding   
Basic (in shares)134.5133.6136.1
Diluted (in shares)134.5133.6137.2

PRGO Balance Sheet

2022-12-31
Consolidated Balance Sheets - USD ($)
shares in Millions, $ in Millions
Dec. 31, 2022
Dec. 31, 2021
Assets  
Cash and cash equivalents$ 600.7$ 1,864.9
Accounts receivable, net of allowance for credit losses of $6.8 and $7.2, respectively697.1652.9
Inventories1,150.31,020.2
Prepaid expenses and other current assets271.8305.8
Current assets held for sale0.016.1
Total current assets2,719.93,859.9
Property, plant and equipment, net926.3864.1
Operating lease assets217.1166.9
Goodwill and indefinite-lived intangible assets3,549.03,004.7
Definite-lived intangible assets, net3,230.22,146.1
Deferred income taxes7.16.5
Other non-current assets367.7377.5
Total non-current assets8,297.46,565.8
Total assets11,017.310,425.7
Liabilities and Shareholders’ Equity  
Accounts payable537.3411.2
Payroll and related taxes136.4118.5
Accrued customer programs139.1125.6
Other accrued liabilities250.2279.4
Accrued income taxes14.416.5
Current indebtedness36.2603.8
Current liabilities held for sale0.032.9
Total current liabilities1,113.61,587.9
Long-term debt, less current portion4,070.42,916.7
Deferred income taxes368.2239.3
Other non-current liabilities623.0530.1
Total non-current liabilities5,061.63,686.1
Total liabilities6,175.25,274.0
Contingencies - Refer to Note 19
Controlling interests:  
Preferred shares, $0.0001 par value per share, 10 shares authorized0.00.0
Ordinary shares, €0.001 par value per share, 10,000 shares authorized6,936.77,043.2
Accumulated other comprehensive income(27.0)35.5
Retained earnings (accumulated deficit)(2,067.6)(1,927.0)
Total shareholders’ equity4,842.15,151.7
Total liabilities and shareholders' equity$ 11,017.3$ 10,425.7
Supplemental Disclosures of Balance Sheet Information  
Preferred shares, issued and outstanding0.00.0
Ordinary shares, issued and outstanding134.7133.8